Leticia Maria de Souza Cordeiro1, Arwa Elsheikh1, Nagavardhini Devisetty1, Donald A Morgan2, Steven N Ebert3, Kamal Rahmouni2, Kavaljit H Chhabra4,5. 1. Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. 2. Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA, USA. 3. Division of Metabolic and Cardiovascular Sciences, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA. 4. Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. Kavaljit_Chhabra@URMC.Rochester.Edu. 5. Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY, USA. Kavaljit_Chhabra@URMC.Rochester.Edu.
Abstract
AIMS/HYPOTHESIS: Melanocortin 4 receptor (MC4R) mutation is the most common cause of known monogenic obesity in humans. Unexpectedly, humans and rodents with MC4R deficiency do not develop hyperglycaemia despite chronic obesity and insulin resistance. To explain the underlying mechanisms for this phenotype, we determined the role of MC4R in glucose homeostasis in the presence and absence of obesity in mice. METHODS: We used global and hypothalamus-specific MC4R-deficient mice to investigate the brain regions that contribute to glucose homeostasis via MC4R. We performed oral, intraperitoneal and intravenous glucose tolerance tests in MC4R-deficient mice that were either obese or weight-matched to their littermate controls to define the role of MC4R in glucose regulation independently of changes in body weight. To identify the integrative pathways through which MC4R regulates glucose homeostasis, we measured renal and adrenal sympathetic nerve activity. We also evaluated glucose homeostasis in adrenaline (epinephrine)-deficient mice to investigate the role of adrenaline in mediating the effects of MC4R in glucose homeostasis. We employed a graded [13C6]glucose infusion procedure to quantify renal glucose reabsorption in MC4R-deficient mice. Finally, we measured the levels of renal glucose transporters in hypothalamus-specific MC4R-deficient mice and adrenaline-deficient mice using western blotting to ascertain the molecular mechanisms underlying MC4R control of glucose homeostasis. RESULTS: We found that obese and weight-matched MC4R-deficient mice exhibited improved glucose tolerance due to elevated glucosuria, not enhanced beta cell function. Moreover, MC4R deficiency selectively in the paraventricular nucleus of the hypothalamus (PVH) is responsible for reducing the renal threshold for glucose as measured by graded [13C6]glucose infusion technique. The MC4R deficiency suppressed renal sympathetic nerve activity by 50% in addition to decreasing circulating adrenaline and renal GLUT2 levels in mice, which contributed to the elevated glucosuria. We further report that adrenaline-deficient mice recapitulated the increased excretion of glucose in urine observed in the MC4R-deficient mice. Restoration of circulating adrenaline in both the MC4R- and adrenaline-deficient mice reversed their phenotype of improved glucose tolerance and elevated glucosuria, demonstrating the role of adrenaline in mediating the effects of MC4R on glucose reabsorption. CONCLUSIONS/ INTERPRETATION: These findings define a previously unrecognised function of hypothalamic MC4R in glucose reabsorption mediated by adrenaline and renal GLUT2. Taken together, our findings indicate that elevated glucosuria due to low sympathetic tone explains why MC4R deficiency does not cause hyperglycaemia despite inducing obesity and insulin resistance. Graphical abstract.
AIMS/HYPOTHESIS: Melanocortin 4 receptor (MC4R) mutation is the most common cause of known monogenic obesity in humans. Unexpectedly, humans and rodents with MC4R deficiency do not develop hyperglycaemia despite chronic obesity and insulin resistance. To explain the underlying mechanisms for this phenotype, we determined the role of MC4R in glucose homeostasis in the presence and absence of obesity in mice. METHODS: We used global and hypothalamus-specific MC4R-deficient mice to investigate the brain regions that contribute to glucose homeostasis via MC4R. We performed oral, intraperitoneal and intravenous glucose tolerance tests in MC4R-deficient mice that were either obese or weight-matched to their littermate controls to define the role of MC4R in glucose regulation independently of changes in body weight. To identify the integrative pathways through which MC4R regulates glucose homeostasis, we measured renal and adrenal sympathetic nerve activity. We also evaluated glucose homeostasis in adrenaline (epinephrine)-deficient mice to investigate the role of adrenaline in mediating the effects of MC4R in glucose homeostasis. We employed a graded [13C6]glucose infusion procedure to quantify renal glucose reabsorption in MC4R-deficient mice. Finally, we measured the levels of renal glucose transporters in hypothalamus-specific MC4R-deficient mice and adrenaline-deficient mice using western blotting to ascertain the molecular mechanisms underlying MC4R control of glucose homeostasis. RESULTS: We found that obese and weight-matched MC4R-deficient mice exhibited improved glucose tolerance due to elevated glucosuria, not enhanced beta cell function. Moreover, MC4R deficiency selectively in the paraventricular nucleus of the hypothalamus (PVH) is responsible for reducing the renal threshold for glucose as measured by graded [13C6]glucose infusion technique. The MC4R deficiency suppressed renal sympathetic nerve activity by 50% in addition to decreasing circulating adrenaline and renal GLUT2 levels in mice, which contributed to the elevated glucosuria. We further report that adrenaline-deficient mice recapitulated the increased excretion of glucose in urine observed in the MC4R-deficient mice. Restoration of circulating adrenaline in both the MC4R- and adrenaline-deficient mice reversed their phenotype of improved glucose tolerance and elevated glucosuria, demonstrating the role of adrenaline in mediating the effects of MC4R on glucose reabsorption. CONCLUSIONS/ INTERPRETATION: These findings define a previously unrecognised function of hypothalamic MC4R in glucose reabsorption mediated by adrenaline and renal GLUT2. Taken together, our findings indicate that elevated glucosuria due to low sympathetic tone explains why MC4R deficiency does not cause hyperglycaemia despite inducing obesity and insulin resistance. Graphical abstract.
Authors: D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee Journal: Cell Date: 1997-01-10 Impact factor: 41.582
Authors: I S Farooqi; G S Yeo; J M Keogh; S Aminian; S A Jebb; G Butler; T Cheetham; S O'Rahilly Journal: J Clin Invest Date: 2000-07 Impact factor: 14.808
Authors: Karine Clément; Heike Biebermann; I Sadaf Farooqi; Lex Van der Ploeg; Barbara Wolters; Christine Poitou; Lia Puder; Fred Fiedorek; Keith Gottesdiener; Gunnar Kleinau; Nicolas Heyder; Patrick Scheerer; Ulrike Blume-Peytavi; Irina Jahnke; Shubh Sharma; Jacek Mokrosinski; Susanna Wiegand; Anne Müller; Katja Weiß; Knut Mai; Joachim Spranger; Annette Grüters; Oliver Blankenstein; Heiko Krude; Peter Kühnen Journal: Nat Med Date: 2018-05-07 Impact factor: 53.440
Authors: Nina Balthasar; Louise T Dalgaard; Charlotte E Lee; Jia Yu; Hisayuki Funahashi; Todd Williams; Manuel Ferreira; Vinsee Tang; Robert A McGovern; Christopher D Kenny; Lauryn M Christiansen; Elizabeth Edelstein; Brian Choi; Olivier Boss; Carl Aschkenasi; Chen-yu Zhang; Kathleen Mountjoy; Toshiro Kishi; Joel K Elmquist; Bradford B Lowell Journal: Cell Date: 2005-11-04 Impact factor: 41.582
Authors: Eric D Berglund; Tiemin Liu; Xingxing Kong; Jong-Woo Sohn; Linh Vong; Zhuo Deng; Charlotte E Lee; Syann Lee; Kevin W Williams; David P Olson; Philipp E Scherer; Bradford B Lowell; Joel K Elmquist Journal: Nat Neurosci Date: 2014-06-08 Impact factor: 24.884
Authors: Tinh-Hai Collet; Béatrice Dubern; Jacek Mokrosinski; Hillori Connors; Julia M Keogh; Edson Mendes de Oliveira; Elana Henning; Christine Poitou-Bernert; Jean-Michel Oppert; Patrick Tounian; Florence Marchelli; Rohia Alili; Johanne Le Beyec; Dominique Pépin; Jean-Marc Lacorte; Andrew Gottesdiener; Rebecca Bounds; Shubh Sharma; Cathy Folster; Bart Henderson; Stephen O'Rahilly; Elizabeth Stoner; Keith Gottesdiener; Brandon L Panaro; Roger D Cone; Karine Clément; I Sadaf Farooqi; Lex H T Van der Ploeg Journal: Mol Metab Date: 2017-07-08 Impact factor: 7.422
Authors: Leticia Maria de Souza Cordeiro; Lauren Bainbridge; Nagavardhini Devisetty; David H McDougal; Dorien J M Peters; Kavaljit H Chhabra Journal: Diabetologia Date: 2022-03-15 Impact factor: 10.460
Authors: Marica Franzago; Annamaria Porreca; Mario D'Ardes; Marta Di Nicola; Luciano Di Tizio; Marco Liberati; Liborio Stuppia; Ester Vitacolonna Journal: Front Nutr Date: 2022-04-29